| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 1,440 | 1,436 | 1,461 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 1,440 | 1,436 | 1,461 | | | Operating Expenses | | Research Development | 13,440 | 23,375 | 46,267 | | Selling General and Administrative | 6,734 | 10,411 | 14,453 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (18,734) | (32,350) | (59,259) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 503 | 1,841 | 3,729 | | Earnings Before Interest And Taxes | (18,231) | (30,509) | (55,530) | | Interest Expense | 61 | 155 | 156 | | Income Before Tax | (18,292) | (30,664) | (55,686) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (18,292) | (30,664) | (55,686) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (18,292) | (30,664) | (55,686) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($18,292) | ($30,664) | ($55,686) |
|
0.11% Nasdaq 
0.01%
Income Statement
